N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide

C30H34FN5O4 — CID 42835214

IUPACN-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide
SMILESCOc1ccc(C(=O)N(CC(=O)N2CCCN(c3ccc(-c4ccc(F)cc4)nn3)CC2)CC2CCCO2)cc1
InChIInChI=1S/C30H34FN5O4/c1-39-25-11-7-23(8-12-25)30(38)36(20-26-4-2-19-40-26)21-29(37)35-16-3-15-34(17-18-35)28-14-13-27(32-33-28)22-5-9-24(31)10-6-22/h5-14,26H,2-4,15-21H2,1H3
InChIKeyGRBQKOPVXMEFJR-UHFFFAOYSA-N
MW547.63 g/mol
LogP3.65
Rot. Bonds8

About N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide

N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide (PubChem CID 42835214) has the molecular formula C30H34FN5O4 and a molecular weight of 547.63 g/mol. Its IUPAC name is N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide.

Molecular Properties

Compound NameN-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide
PubChem CID42835214
Molecular FormulaC30H34FN5O4
Molecular Weight547.63 g/mol
Exact Mass547.26
IUPAC NameN-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide
SMILESCOc1ccc(C(=O)N(CC(=O)N2CCCN(c3ccc(-c4ccc(F)cc4)nn3)CC2)CC2CCCO2)cc1
InChIInChI=1S/C30H34FN5O4/c1-39-25-11-7-23(8-12-25)30(38)36(20-26-4-2-19-40-26)21-29(37)35-16-3-15-34(17-18-35)28-14-13-27(32-33-28)22-5-9-24(31)10-6-22/h5-14,26H,2-4,15-21H2,1H3
InChIKeyGRBQKOPVXMEFJR-UHFFFAOYSA-N
XLogP3.65
TPSA88.10 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500547.63
LogP ≤ 53.65
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide?
The IUPAC name of N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide (CID 42835214) is N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide.
What is the SMILES notation for N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide?
The canonical SMILES for N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide is COc1ccc(C(=O)N(CC(=O)N2CCCN(c3ccc(-c4ccc(F)cc4)nn3)CC2)CC2CCCO2)cc1.
What is the InChIKey of N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide?
The InChIKey is GRBQKOPVXMEFJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H34FN5O4/c1-39-25-11-7-23(8-12-25)30(38)36(20-26-4-2-19-40-26)21-29(37)35-16-3-15-34(17-18-35)28-14-13-27(32-33-28)22-5-9-24(31)10-6-22/h5-14,26H,2-4,15-21H2,1H3.
What are the key properties of N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide?
N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide has a molecular weight of 547.63 g/mol, XLogP of 3.65, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl]-2-oxoethyl]-4-methoxy-N-(oxolan-2-ylmethyl)benzamide is sourced from PubChem (CID 42835214), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).